MedPath

The efficacy of low dose botulinum toxin A VS hand splint for thumb in palm deformity in spastic cerebral palsy children : A randomized controlled trial

Phase 4
Conditions
Thumb in palm deformity frequently seen in children with spastic cerebral palsyThe consequences can be burdensome and lifelongImpairs the ability to use the thumb Limits hand function and range of motion Management of thumb in palm deformity is multi-disciplinary
Thumb in palm deformity, hand function, spastic cerebral palsy, Botulinum toxin type A, hand splint, spasticity, range of motion
Registration Number
TCTR20230417007
Lead Sponsor
Ratchadapisek Research Funds(For graduate students, residents, fellows)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
36
Inclusion Criteria

1.Spastic CP with Thumb in palm deformity and impaired with hand functional use and/or limiting activities of daily living, 2.Inform consent and assent signed, 3.Between 3 and 8 years of age, 4. Modified ashworth scale (MAS) of adductor pollicis = 1-3, 5.Can follow at lease 1 step command

Exclusion Criteria

1.Unstable medical or neurological condition, 2.Previous hand/arm surgery, 3.BoNT-A injections within the last 6 month, 4.Fixed contractures of upper limb, 5.Joint instability, 6.Can not wear a splint, 7.Contraindication of BoNT-A, lidocaine and Prilociane

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hand function at 4 week and 12 week after start the intervention Quality of upper extremity skills test-Grasp domain
Secondary Outcome Measures
NameTimeMethod
Spasticity at 4 week and 12 week after start the intervention Modified Ashworth Scale,Range of motion at 4 week and 12 week after start the intervention Range of motion scale,Satisfaction at 4 week and 12 week after start the intervention Satisfaction scale
© Copyright 2025. All Rights Reserved by MedPath